National

US Senate confirms Trump nominee Ratcliffe as CIA director

Jan 24, 2025

Washington [US], January 24: A majority of the U.S. Senate on Thursday backed President Donald Trump's nominee John Ratcliffe.
AS a former House of Representatives member who served as Director of National Intelligence during Trump's first term, as director of the CIA.
The Senate voted to confirm Ratcliffe by 74-25, as 20 Democrats and one independent joined Republicans in backing the nomination.
The Republican-led Senate has been working to confirm Trump's nominees for top positions in his administration as quickly as possible, starting with his national security team.
Former Republican Senator Marco Rubio was confirmed on Monday, the day of Trump's inauguration, and the Senate is due to vote on Friday on Trump's nomination of former Fox News personality Pete Hegseth to be secretary of defense.
The Senate Intelligence Committee has scheduled a hearing on Jan. 30 for former U.S. Representative Tulsi Gabbard, Trump's nominee to be Director of National Intelligence in his second term.
Source: Fijian Broadcasting Cooperation

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026